On July 31, we discussed Moderna, one of the two big C-19 vaccine manufacturers. We discussed two situations: earnings and the longer-term trend. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:#mRNA Share: Mark W. Guthner, CFA Previous Post Microstrategy Update: MSTRNext PostNVIDIA: NVDA You Might Also Like Covered Call Report November 27, 2018 MIK: Michaels Companies December 9, 2020 Federal Express (FDX): Back in the Dog House October 30, 2021
You Might Also Like Covered Call Report November 27, 2018 MIK: Michaels Companies December 9, 2020 Federal Express (FDX): Back in the Dog House October 30, 2021
